Brukinsa (zanubrutinib)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Brukinsa (zanubrutinib), covering 2021-11-03 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM [Phase 2]